Potential factors of cytokeratin fragment 21-1 and cancer embryonic antigen for mediastinal lymph node metastasis in lung cancer

Objective: Lung cancer is a common malignant tumor, characterized by being difficult to detect and lacking specific clinical manifestations. This study aimed to find out the risk factors of mediastinal lymph node metastasis and explore the correlation between serum tumor markers and mediastinal lymp...

Full description

Bibliographic Details
Main Authors: Jing Tang, Hui-Ye Shu, Tie Sun, Li-Juan Zhang, Min Kang, Ping Ying, Qian Ling, Jie Zou, Xu-Lin Liao, Yi-Xin Wang, Hong Wei, Yi Shao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.1009141/full
_version_ 1811209578462838784
author Jing Tang
Hui-Ye Shu
Tie Sun
Li-Juan Zhang
Min Kang
Ping Ying
Qian Ling
Jie Zou
Xu-Lin Liao
Yi-Xin Wang
Hong Wei
Yi Shao
author_facet Jing Tang
Hui-Ye Shu
Tie Sun
Li-Juan Zhang
Min Kang
Ping Ying
Qian Ling
Jie Zou
Xu-Lin Liao
Yi-Xin Wang
Hong Wei
Yi Shao
author_sort Jing Tang
collection DOAJ
description Objective: Lung cancer is a common malignant tumor, characterized by being difficult to detect and lacking specific clinical manifestations. This study aimed to find out the risk factors of mediastinal lymph node metastasis and explore the correlation between serum tumor markers and mediastinal lymph node metastasis and lung cancer prognosis.Methods: A retrospective study of 3,042 lung cancer patients (330 patients with mediastinal lymph node metastasis and 2,712 patients without mediastinal lymph node metastasis) collected from the First Affiliated Hospital of Nanchang University from April 1999 to July 2020. The patients were divided into two groups, namely, mediastinal lymph node metastasis group and non-mediastinal lymph node metastasis group. Student’s t test, non-parametric rank sum test and chi-square test were used to describe whether there is a significant difference between the two groups. We compared the serum biomarkers of the two groups of patients, including exploring serum alkaline phosphatase (ALP), calcium hemoglobin (HB), alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA), CA125, CA-199, CA -153, cytokeratin fragment 19 (CYFRA 21-1), total prostate specific antigen (TPSA), neuron-specific enolase (NSE) levels and the incidence and prognosis of lung cancer mediastinal lymph node metastasis. Binary logistic regression analysis was used to determine its risk factors, and receiver operating curve (ROC) analysis was used to evaluate its diagnostic value for mediastinal lymph node metastasis.Results: Binary logistic regression analysis showed that carcinoembryonic antigen and CYFRA 21-1 were independent risk factors for mediastinal lymph node metastasis in patients with lung cancer (p < 0.001 and p = 0.002, respectively). The sensitivity and specificity of CEA for the diagnosis of mediastinal lymph node metastasis were 90.2 and 7.6%, respectively; CYFRA 21-1 were 0.6 and 99.0%, respectively.Conclusion: Serum CEA and CYFRA 21-1 have predictive value in the diagnosis of mediastinal lymph node metastasis in patients with lung cancer.
first_indexed 2024-04-12T04:41:59Z
format Article
id doaj.art-269dcd78b03c42d6a8fe4961f7db51c7
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-04-12T04:41:59Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-269dcd78b03c42d6a8fe4961f7db51c72022-12-22T03:47:35ZengFrontiers Media S.A.Frontiers in Genetics1664-80212022-09-011310.3389/fgene.2022.10091411009141Potential factors of cytokeratin fragment 21-1 and cancer embryonic antigen for mediastinal lymph node metastasis in lung cancerJing Tang0Hui-Ye Shu1Tie Sun2Li-Juan Zhang3Min Kang4Ping Ying5Qian Ling6Jie Zou7Xu-Lin Liao8Yi-Xin Wang9Hong Wei10Yi Shao11Department of Oncology, The Affiliated Zhuzhou Hospital Xiangya Medical College, Central South University, Zhuzhou, Hunan, ChinaDepartment of Ophthalmology, Jiangxi Branch of National Clinical Research Center for Ocular Disease, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaDepartment of Ophthalmology, Jiangxi Branch of National Clinical Research Center for Ocular Disease, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaDepartment of Ophthalmology, Jiangxi Branch of National Clinical Research Center for Ocular Disease, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaDepartment of Ophthalmology, Jiangxi Branch of National Clinical Research Center for Ocular Disease, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaDepartment of Ophthalmology, Jiangxi Branch of National Clinical Research Center for Ocular Disease, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaDepartment of Ophthalmology, Jiangxi Branch of National Clinical Research Center for Ocular Disease, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaDepartment of Ophthalmology, Jiangxi Branch of National Clinical Research Center for Ocular Disease, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaDepartment of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, ChinaSchool of Optometry and Vision Science, Cardiff University, Cardiff, United KingdomDepartment of Ophthalmology, Jiangxi Branch of National Clinical Research Center for Ocular Disease, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaDepartment of Ophthalmology, Jiangxi Branch of National Clinical Research Center for Ocular Disease, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaObjective: Lung cancer is a common malignant tumor, characterized by being difficult to detect and lacking specific clinical manifestations. This study aimed to find out the risk factors of mediastinal lymph node metastasis and explore the correlation between serum tumor markers and mediastinal lymph node metastasis and lung cancer prognosis.Methods: A retrospective study of 3,042 lung cancer patients (330 patients with mediastinal lymph node metastasis and 2,712 patients without mediastinal lymph node metastasis) collected from the First Affiliated Hospital of Nanchang University from April 1999 to July 2020. The patients were divided into two groups, namely, mediastinal lymph node metastasis group and non-mediastinal lymph node metastasis group. Student’s t test, non-parametric rank sum test and chi-square test were used to describe whether there is a significant difference between the two groups. We compared the serum biomarkers of the two groups of patients, including exploring serum alkaline phosphatase (ALP), calcium hemoglobin (HB), alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA), CA125, CA-199, CA -153, cytokeratin fragment 19 (CYFRA 21-1), total prostate specific antigen (TPSA), neuron-specific enolase (NSE) levels and the incidence and prognosis of lung cancer mediastinal lymph node metastasis. Binary logistic regression analysis was used to determine its risk factors, and receiver operating curve (ROC) analysis was used to evaluate its diagnostic value for mediastinal lymph node metastasis.Results: Binary logistic regression analysis showed that carcinoembryonic antigen and CYFRA 21-1 were independent risk factors for mediastinal lymph node metastasis in patients with lung cancer (p < 0.001 and p = 0.002, respectively). The sensitivity and specificity of CEA for the diagnosis of mediastinal lymph node metastasis were 90.2 and 7.6%, respectively; CYFRA 21-1 were 0.6 and 99.0%, respectively.Conclusion: Serum CEA and CYFRA 21-1 have predictive value in the diagnosis of mediastinal lymph node metastasis in patients with lung cancer.https://www.frontiersin.org/articles/10.3389/fgene.2022.1009141/fulllung cancermediastinal lymph node metastasis potential indicatorstumor blood markerscancerrisk factors
spellingShingle Jing Tang
Hui-Ye Shu
Tie Sun
Li-Juan Zhang
Min Kang
Ping Ying
Qian Ling
Jie Zou
Xu-Lin Liao
Yi-Xin Wang
Hong Wei
Yi Shao
Potential factors of cytokeratin fragment 21-1 and cancer embryonic antigen for mediastinal lymph node metastasis in lung cancer
Frontiers in Genetics
lung cancer
mediastinal lymph node metastasis potential indicators
tumor blood markers
cancer
risk factors
title Potential factors of cytokeratin fragment 21-1 and cancer embryonic antigen for mediastinal lymph node metastasis in lung cancer
title_full Potential factors of cytokeratin fragment 21-1 and cancer embryonic antigen for mediastinal lymph node metastasis in lung cancer
title_fullStr Potential factors of cytokeratin fragment 21-1 and cancer embryonic antigen for mediastinal lymph node metastasis in lung cancer
title_full_unstemmed Potential factors of cytokeratin fragment 21-1 and cancer embryonic antigen for mediastinal lymph node metastasis in lung cancer
title_short Potential factors of cytokeratin fragment 21-1 and cancer embryonic antigen for mediastinal lymph node metastasis in lung cancer
title_sort potential factors of cytokeratin fragment 21 1 and cancer embryonic antigen for mediastinal lymph node metastasis in lung cancer
topic lung cancer
mediastinal lymph node metastasis potential indicators
tumor blood markers
cancer
risk factors
url https://www.frontiersin.org/articles/10.3389/fgene.2022.1009141/full
work_keys_str_mv AT jingtang potentialfactorsofcytokeratinfragment211andcancerembryonicantigenformediastinallymphnodemetastasisinlungcancer
AT huiyeshu potentialfactorsofcytokeratinfragment211andcancerembryonicantigenformediastinallymphnodemetastasisinlungcancer
AT tiesun potentialfactorsofcytokeratinfragment211andcancerembryonicantigenformediastinallymphnodemetastasisinlungcancer
AT lijuanzhang potentialfactorsofcytokeratinfragment211andcancerembryonicantigenformediastinallymphnodemetastasisinlungcancer
AT minkang potentialfactorsofcytokeratinfragment211andcancerembryonicantigenformediastinallymphnodemetastasisinlungcancer
AT pingying potentialfactorsofcytokeratinfragment211andcancerembryonicantigenformediastinallymphnodemetastasisinlungcancer
AT qianling potentialfactorsofcytokeratinfragment211andcancerembryonicantigenformediastinallymphnodemetastasisinlungcancer
AT jiezou potentialfactorsofcytokeratinfragment211andcancerembryonicantigenformediastinallymphnodemetastasisinlungcancer
AT xulinliao potentialfactorsofcytokeratinfragment211andcancerembryonicantigenformediastinallymphnodemetastasisinlungcancer
AT yixinwang potentialfactorsofcytokeratinfragment211andcancerembryonicantigenformediastinallymphnodemetastasisinlungcancer
AT hongwei potentialfactorsofcytokeratinfragment211andcancerembryonicantigenformediastinallymphnodemetastasisinlungcancer
AT yishao potentialfactorsofcytokeratinfragment211andcancerembryonicantigenformediastinallymphnodemetastasisinlungcancer